English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 904050      Online Users : 816
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    期刊論文 [327/330]
    圖書 [1/1]
    會議論文/會議摘要 [115/179]

    Community Statistics


    近3年內發表的文件:74(14.51%)
    含全文筆數:443(86.86%)

    文件下載次數統計
    下載大於0次:443(100.00%)
    下載大於100次:426(96.16%)
    檔案下載總次數:178043(3.32%)

    最後更新時間: 2024-12-01 03:12

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 61-70 of 510. (51 Page(s) Totally)
    << < 2 3 4 5 6 7 8 9 10 11 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2022-04-15 The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan American Journal of Cancer Research. 2022 Apr 15;12(4):1884-1898.
    2022-04-11 Identification of distinct slow mode of reversible adaptation of pancreatic ductal adenocarcinoma to the prolonged acidic pH microenvironment Journal of Experimental and Clinical Cancer Research. 2022 Apr 11;41:Article number 137.
    2022-04 A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study British Journal of Cancer. 2022 Apr;126(7):1018-1026.
    2022-04 Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials Journal for Immunotherapy of Cancer. 2022 Apr;10(4):Article number e004273.
    2022-02-24 Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway International Journal of Molecular Sciences. 2022 Feb 24;23(5):Article number 2608.
    2022-02-16 Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma Cancers. 2022 Feb 16;14(4):Article number 1005.
    2022-02-15 Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1 American Journal of Cancer Research. 2022 Feb 15;12(2):713-728.
    2022-02-01 A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1 Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):378.
    2022-02-01 A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550.
    2022-02 Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010) International Journal of Urology. 2022 Feb;29(2):121-127.

    Showing items 61-70 of 510. (51 Page(s) Totally)
    << < 2 3 4 5 6 7 8 9 10 11 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback